For the quarter ended June 2025, Edgewell Personal Care (EPC) reported revenue of $627.2 million, down 3.2% over the same period last year. EPS came in at $0.92, compared to $1.22 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $657.04 million, representing a surprise of -4.54%. The company delivered an EPS surprise of -8.91%, with the consensus EPS estimate being $1.01.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Edgewell Personal performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Net Sales- Feminine Care: $66.8 million compared to the $72.13 million average estimate based on three analysts. The reported number represents a change of -10.5% year over year.
- Net Sales- Wet Shave: $317 million versus $322.83 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +0.2% change.
- Net Sales- Sun and Skin Care: $243.4 million compared to the $262.08 million average estimate based on three analysts. The reported number represents a change of -5.3% year over year.
View all Key Company Metrics for Edgewell Personal here>>>
Shares of Edgewell Personal have returned +2% over the past month versus the Zacks S&P 500 composite's +1% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Edgewell Personal Care Company (EPC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
